BRKR

SEC source: 0001415889-23-007206 · form4-05032023_080522.xml · nonDerivative · entry 1

LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 38,352,034

F1 · shares: The shares represented by this transaction were sold pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.31 to $79.30, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001415889-23-006920 · form4-04262023_080453.xml · nonDerivative · entry 6

LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 38,262,287

F1 · shares: The shares represented by this transaction were sold pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.58 to $80.67, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001415889-23-006920 · form4-04262023_080453.xml · nonDerivative · entry 5

LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 38,262,747

F1 · shares: The shares represented by this transaction were sold pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.51 to $80.35, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001415889-23-006920 · form4-04262023_080453.xml · nonDerivative · entry 4

LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 38,269,921

F1 · shares: The shares represented by this transaction were sold pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.515 to $79.50, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001415889-23-006920 · form4-04262023_080453.xml · nonDerivative · entry 3

LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 38,298,156

F1 · shares: The shares represented by this transaction were sold pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.51 to $78.45, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001415889-23-006920 · form4-04262023_080453.xml · nonDerivative · entry 2

LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 38,349,926

F1 · shares: The shares represented by this transaction were sold pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.585 to $81.93, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001415889-23-006920 · form4-04262023_080453.xml · nonDerivative · entry 1

LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 38,352,034

F1 · shares: The shares represented by this transaction were sold pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.57 to $81.52, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001415889-23-001202 · form4-01192023_040101.xml · nonDerivative · entry 1

Friend Cynthia M · CIK 0001675108 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,576

F1 · shares: The shares represented by this transaction were sold pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person.

SEC source: 0001415889-23-000685 · form4-01092023_090140.xml · nonDerivative · entry 1

Ma Philip · CIK 0001919486 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,586

F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2024. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock.

SEC source: 0001415889-23-000684 · form4-01092023_090157.xml · nonDerivative · entry 1

Anderson Bonnie H · CIK 0001588970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,652

F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2024. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock.

SEC source: 0001415889-23-000683 · form4-01092023_090109.xml · nonDerivative · entry 1

LINTON WILLIAM A · CIK 0001243154 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,048

F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2024. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock.

SEC source: 0001415889-23-000681 · form4-01092023_090102.xml · nonDerivative · entry 1

PACKER RICHARD A · CIK 0001237765 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,877

F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2024. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock.

SEC source: 0001415889-23-000680 · form4-01092023_090105.xml · nonDerivative · entry 1

ROSENTHAL BOB · CIK 0001203911 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,770

F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2024. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock.

SEC source: 0001415889-23-000679 · form4-01092023_090121.xml · nonDerivative · entry 1

Kastner Marc A · CIK 0001570183 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,021

F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2024. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock.

SEC source: 0001415889-23-000677 · form4-01092023_090153.xml · nonDerivative · entry 1

Requardt Hermann Fritz · CIK 0001651105 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,770

F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2024. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock.

SEC source: 0001415889-23-000678 · form4-01092023_090134.xml · nonDerivative · entry 1

ORNELL JOHN A · CIK 0001186875 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,770

F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2024. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock.

SEC source: 0001415889-23-000676 · form4-01092023_090159.xml · nonDerivative · entry 1

Friend Cynthia M · CIK 0001675108 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,497

F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2024. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock.

SEC source: 0001415889-23-000675 · form4-01092023_090110.xml · nonDerivative · entry 1

Perkins Adelene Q · CIK 0001375124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,949

F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2024. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock.

SEC source: 0001415889-22-012696 · form4-12192022_091237.xml · nonDerivative · entry 1

LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,500,264

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person.

SEC source: 0001415889-22-012171 · form4-12072022_101225.xml · derivative · entry 5

PACKER RICHARD A · CIK 0001237765 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2024-01-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock option granted to the Reporting Person on January 6, 2014 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.

SEC source: 0001415889-22-012171 · form4-12072022_101225.xml · derivative · entry 4

PACKER RICHARD A · CIK 0001237765 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2023-01-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option granted to the Reporting Person on January 7, 2013 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.

SEC source: 0001415889-22-012171 · form4-12072022_101225.xml · nonDerivative · entry 3

PACKER RICHARD A · CIK 0001237765 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,907

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.78 to $66.52, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001415889-22-012171 · form4-12072022_101225.xml · nonDerivative · entry 2

PACKER RICHARD A · CIK 0001237765 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,907

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-22-012171 · form4-12072022_101225.xml · nonDerivative · entry 1

PACKER RICHARD A · CIK 0001237765 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,907

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-22-012167 · form4-12072022_101206.xml · derivative · entry 2

LINTON WILLIAM A · CIK 0001243154 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2023-01-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock option granted to the Reporting Person on January 7, 2013 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.

SEC source: 0001415889-22-012167 · form4-12072022_101206.xml · nonDerivative · entry 1

LINTON WILLIAM A · CIK 0001243154 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,078

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-22-011485 · form4-11172022_091158.xml · derivative · entry 3

Kastner Marc A · CIK 0001570183 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2026-01-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option granted to the Reporting Person on January 5, 2016 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.

SEC source: 0001415889-22-011485 · form4-11172022_091158.xml · nonDerivative · entry 2

Kastner Marc A · CIK 0001570183 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,051

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.545 to $71.120, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001415889-22-011485 · form4-11172022_091158.xml · nonDerivative · entry 1

Kastner Marc A · CIK 0001570183 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,051

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-22-008621 · form4-08152022_010837.xml · derivative · entry 2

Busse Falko · CIK 0001739999 · PRESIDENT, BIOSPIN GROUP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,719

Underlying: Common Stock · 4,719 shares

Expires 2032-08-11

F2 · derivative.exercise_date: The stock option granted to the Reporting Person on August 11, 2022 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.

SEC source: 0001415889-22-008621 · form4-08152022_010837.xml · nonDerivative · entry 1

Busse Falko · CIK 0001739999 · PRESIDENT, BIOSPIN GROUP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,333

F1 · shares: The Restricted Stock Units granted to the Reporting Person on August 11, 2022 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.

SEC source: 0001415889-22-008619 · form4-08152022_010858.xml · derivative · entry 2

Prause Burkhard · CIK 0001544726 · PRES. & CEO, BRUKER BEST

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,472

Underlying: Common Stock · 2,472 shares

Expires 2032-08-11

F2 · derivative.exercise_date: The stock option granted to the Reporting Person on August 11, 2022 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.

SEC source: 0001415889-22-008619 · form4-08152022_010858.xml · nonDerivative · entry 1

Prause Burkhard · CIK 0001544726 · PRES. & CEO, BRUKER BEST

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,563

F1 · shares: The Restricted Stock Units granted to the Reporting Person on August 11, 2022 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.

SEC source: 0001415889-22-008616 · form4-08152022_010847.xml · derivative · entry 2

Herman Gerald N · CIK 0001327294 · EXECUTIVE VICE PRESIDENT, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,686

Underlying: Common Stock · 12,686 shares

Expires 2032-08-11

F2 · derivative.exercise_date: The stock option granted to the Reporting Person on August 11, 2022 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.

SEC source: 0001415889-22-008616 · form4-08152022_010847.xml · nonDerivative · entry 1

Herman Gerald N · CIK 0001327294 · EXECUTIVE VICE PRESIDENT, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,704

F1 · shares: The Restricted Stock Units granted to the Reporting Person on August 11, 2022 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.

SEC source: 0001415889-22-008613 · form4-08152022_010858.xml · derivative · entry 2

Munch Mark · CIK 0001544635 · EXEC VP&PRES BRUKER NANO INC.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,938

Underlying: Common Stock · 12,938 shares

Expires 2032-08-11

F2 · derivative.exercise_date: The stock option granted to the Reporting Person on August 11, 2022 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.

SEC source: 0001415889-22-008613 · form4-08152022_010858.xml · nonDerivative · entry 1

Munch Mark · CIK 0001544635 · EXEC VP&PRES BRUKER NANO INC.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,879

F1 · shares: The Restricted Stock Units granted to the Reporting Person on August 11, 2022 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.

SEC source: 0001415889-22-008609 · form4-08152022_010844.xml · derivative · entry 8

LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,550

Underlying: Common Stock · 40,550 shares

Expires 2027-08-11

F3 · derivative.exercise_date: The stock option granted to the Reporting Person on August 11, 2022 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.

SEC source: 0001415889-22-008609 · form4-08152022_010844.xml · nonDerivative · entry 1

LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,497,106

F1 · shares: 1. The Restricted Stock Units granted to the Reporting Person on August 11, 2022 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.

SEC source: 0001415889-22-008453 · form4-08102022_010803.xml · nonDerivative · entry 2

Munch Mark · CIK 0001544635 · EXEC VP&PRES BRUKER NANO INC.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,109

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person.

SEC source: 0001415889-22-008452 · form4-08102022_010811.xml · nonDerivative · entry 2

LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,457,083

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person.

SEC source: 0001415889-22-008453 · form4-08102022_010803.xml · nonDerivative · entry 1

Munch Mark · CIK 0001544635 · EXEC VP&PRES BRUKER NANO INC.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,624

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person.

SEC source: 0001415889-22-008452 · form4-08102022_010811.xml · nonDerivative · entry 1

LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,463,102

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person.

SEC source: 0001415889-22-008417 · form4-08092022_010859.xml · nonDerivative · entry 2

Munch Mark · CIK 0001544635 · EXEC VP&PRES BRUKER NANO INC.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,765

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person.

SEC source: 0001415889-22-008416 · form4-08092022_010811.xml · nonDerivative · entry 2

LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,468,178

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person.

SEC source: 0001415889-22-008417 · form4-08092022_010859.xml · nonDerivative · entry 1

Munch Mark · CIK 0001544635 · EXEC VP&PRES BRUKER NANO INC.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,892

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person.

SEC source: 0001415889-22-008416 · form4-08092022_010811.xml · nonDerivative · entry 1

LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,473,318

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person.

SEC source: 0001415889-22-005013 · form4-05162022_010505.xml · nonDerivative · entry 1

LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,476,233

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.30 to $57.98, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001415889-22-005134 · form4a-05172022_010507.xml · nonDerivative · entry 1

LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,476,233

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.30 to $57.98, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001415889-22-003704 · form4-04042022_010425.xml · nonDerivative · entry 1

Ma Philip · CIK 0001919486 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,616

F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on April 1, 2023. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock.